Your browser doesn't support javascript.
loading
Perceptions Associated with Noncompliance to Community-Wide Mass Drug Administration for Soil-Transmitted Helminths.
Sindhu, Kulandaipalayam Natarajan; Aruldas, Kumudha; Kaliappan, Saravanakumar Puthupalayam; Mahendran, Elavarasan; Walson, Judd L; Means, Arianna Rubin; Ajjampur, Sitara Swarna Rao.
Afiliación
  • Sindhu KN; The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India.
  • Aruldas K; The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India.
  • Kaliappan SP; The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India.
  • Mahendran E; The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India.
  • Walson JL; Department of Global Health, University of Washington, Seattle, Washington.
  • Means AR; Department of Medicine, University of Washington, Seattle, Washington.
  • Ajjampur SSR; Department of Pediatrics, University of Washington, Seattle, Washington.
Am J Trop Med Hyg ; 109(4): 830-834, 2023 10 04.
Article en En | MEDLINE | ID: mdl-37604467
ABSTRACT
Mass drug administration (MDA) is a key strategy for the control of soil-transmitted helminths (STHs). Within MDA programs, poor and non-random compliance threaten successful control of STHs. A case-control study was conducted comparing perceptions among non-compliant participants with compliant participants during a community-wide MDA (cMDA) with albendazole in southern India. Common reasons cited for non-compliance were that the individual was not infected with STH (97.4%), the perception that he/she was healthy (91%), fear of side-effects (12.8%), and dislike of consuming tablets (10.3%). Noncompliance was associated with poor awareness of intestinal worms (odds ratio [OR] 9.63, 95% CI 2.11-43.84), the perception that cMDA was only required for those with worms (OR 2.14, 95% CI 1.06-4.36), and the perception that the drug is not safe during pregnancy (OR 2.19, 95% CI 1.18-4.07) or when on concomitant medications (OR 3.14, 95% CI 1.38-7.15). Understanding of perceptions driving noncompliance can provide valuable insights to optimize participation during MDA for STHs.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Helmintiasis / Helmintos / Antihelmínticos Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Am J Trop Med Hyg Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Helmintiasis / Helmintos / Antihelmínticos Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Am J Trop Med Hyg Año: 2023 Tipo del documento: Article País de afiliación: India